25 August 2020
New authorisation for our bio-fungicide in Australia
Today Eden announces that our biofungicide product has gained regstration in an Australia. Marketed as Mevalone® in the EU, it will be sold under the brand name NovellusTM in Australia, for use on grapes against botrytis. For full details please click here.
5 August 2020
New authorisation for Cedroz™ bionematicide in Greece
Eden's commercial collaborator, Eastman Chemical Company ("Eastman"), has received authorisation for the sale of Cedroz™ in Greece, to be sold to the market via regional distributor K&N Efthymiadis ('KNE').
For full details click here.
10 July 2020
Dr. Aoife Dillon joins as Global Head of Biology and Development
As Eden's new Global Head of Biology and Development, Aoife will undertake global responsibility for developing the Company's product pipeline from a biology standpoint. The wealth of experience that Aoife brings to the role will be invaluable for driving our development of sustainable biopesticides and plastic-free encapsulation technology. Click here for full details.
1 July 2020
Opening of new laboratories at Milton Park
We are pleased to confirm that we have moved to new offices and laboratory facilities at Milton Park. The move is an important part of our ambitious growth plans and more detail can be found here.
20 May 2020
New Authorisations for Mevalone and Cedroz
Eden's biofungicide Mevalone has been approved in Greece for use on both tomatoes and olives for several minor diseases. Our bionematicide product Cedroz has also received full authorisatuion in the Netherlands for use in glasshouses on a wide range of crops. Read the full detail here.
28 April 2020
Five Minutes with Sean Smith
Sean Smith, Eden’s CEO, sat down with Liz Gyekye from Bio Market Insights to discuss the transformation and future outlook of the farming sector, as well as Eden’s work and ambitions for the future.
Read the full article here.
23 April 2020
GHP Award for Sustainable Crop Protection
Eden have been recognised as the Leading Innovators of Sustainable Crop Protection Solutions - UK by Global Health & Pharma for our work in developing crop protection solutions which are a reliable part of crop protection prgrammes and have environmentally favourable profiles.
Increasing regulation is driving innovation across the crop protection industry and we are pleased that our work is recognised for the value it offers to both farmers and consumer alike.
15 April 2020
Director of Regulatory Affairs
Eden is pleased to announce the appointment of Dr. Michael Carroll as Director of Regulatory Affairs.
Mike is a leading figure in the field of crop protection products development and registration. He brings international experience to the team having worked in the UK, Germany, Belgium and the USA, with over 30 years' experience gained in the agrochemical industries. Mike served tenures of over 10 years at both Dow AgroSciences and Monsanto Agricultural Group, holding the various positions including Global Registration Manager and European Registration Manager. At Monsanto and Dow AgroSciences, Mike's responsibilities included the global launch of herbicides and fungicides, experience which will be highly relevant as Eden executes on plans to expand its product offering.
More recently, Mike served as Head of Research and Development for Arysta EMEA, the largest region in Arysta LifeSciences. He was responsible for early stage development and registration of new formulations, the defence of existing active substances, chemical and biosolutions, and ensuring REACH (Registration, Evaluation, Authorisation and restriction of Chemicals) compliance in Europe. For the past year, Michael has been working for TSG Consulting(AIM:SAG) an AIM-quoted Science Group company that provides regulatory and scientific support to chemical companies around the world.
Mike holds BSc and PhD degrees in biochemistry from the UK universities of Bath and London, respectively, and throughout his career has shown interest in how local politics ultimately controls the regulatory process. Mike is a frequent speaker and published author, regularly participating in Informa Ag Chem and Generics speciality conferences and British Crop Production Council conferences. In 2019, he presented at both of these events on the topic of "The EU General Food Law and Transparency".
CEO Sean Smith commented: "Mike is a key appointment that further demonstrates our focus on building a high-calibre team around the core functions within our business. He brings significant capabilities to the Company in the critical areas of product registration and regulatory compliance. Mike has a wealth of international experience which has given him invaluable expertise in product registration globally. Mike comes with a long track record of driving successful regulatory outcomes in the crop protection industry, a network of key industry influencers, and experience in senior roles at industry leaders such as Dow AgroSciences and Monsanto. We are pleased to welcome him to Eden."
8 April 2020
Organic certification in Italy and Spain
Eden is pleased to announce that our foliar biofungicide product Mevalone™, branded "3LOGY®" in Italy and "Araw®" in Spain, has received certification for use in organic farming. The certification, received by Eden's partner Sipcam Oxon S.p.A ("Sipcam"), follows the initial approval of Eden's three EU-registered active ingredients for use in organic farming earlier this year.
Eden's partner Sipcam has been selling 3LOGY and Araw for the primary use of treating and preventing botrytis. Botrytis is a widespread fungal disease that causes grey mould on many fruits and vegetables leading to the rapid loss of commercially valuable crops. Following certification, the product can now also be used in organic vineyards, creating a significant opportunity for Eden to enter a new market. Spain and Italy are in the top three EU countries with the largest organic farming areas; Spain has the overall largest area of permanent crops (e.g. grapes, olives, nuts). More specifically, Spain and Italy each have more than 100,000 hectares of organic grapes harvested across the country, followed by France with over 78,000 hectares. It is anticipated that an equivalent inclusion will soon be received by Eden's partner Sumi Agro in France.
As consumer sentiment for sustainable and organic products has grown in recent years, the European viniculture industry has increased its attention and commitment to sustainability and protecting the environment. Europe will account for 78% of the global organic wine market by 2022, and globally the market is projected to grow at 9.2% CAGR from 2017-22. In the UK, consumers are willing to pay 38% more for organic wine and there is a broad audience of environmentally conscious consumers who now opt for a grape with a greener footprint.
Sean Smith, Chief Executive Officer of Eden, said: "We are pleased to begin selling our products to organic growers in Italy and Spain, a commercial development that will contribute to the enlargement of our addressable market in Europe and to the ongoing growth of sales in these important countries. Sustainable farming practices are clearly a priority for wine producers globally as the organic wine market has increased rapidly over recent years. Italy and Spainare at the centre of the movement, with organic wine production forecast to increase by 70% in Spain between 2018-2023 and Italy's organic vineyards amount for 15.5% of its total vineyards, the highest amount in the world. Our products give organic growers an effective and sustainable solution comparable to conventional chemistry but in a way that is aligned with the fundamental elements of organic production."
28 February 2020
Placing, Subscription & Open Offer
Eden proposes to raise, subject to certain conditions (i) £10.1 million (before expenses) by the conditional Placing and Subscription of 168,333,334 new Ordinary Shares at the Issue Price to certain institutional and other investors including Sipcam; and (ii) up to approximately £0.5 million (before expenses) by way of an Open Offer made to Qualifying Shareholders of up to 8,287,573 new Ordinary Shares at the Issue Price.
The net proceeds of the Placing, Subscription and Open Offer will be used to advance the development, registration and commercialisation of new product categories, including new insecticide formulations and seed treatments, as well as to provide additional working capital for the Group associated with the new development areas.
A General Meeting will be held at DAC Beachcroft LLP, 25 Walbrook, London EC4N 8AF at 11.00 a.m. on 18 March 2020.
Further details can be found here.